• Please log in or register to access this feature.

Original Article

You have full text access to this OnlineOpen article

Characterization of Cells with a High Aldehyde Dehydrogenase Activity from Cord Blood and Acute Myeloid Leukemia Samples

  1. Daniel J. Pearce1,
  2. David Taussig1,3,
  3. Catherine Simpson2,
  4. Kirsty Allen2,
  5. Ama Z. Rohatiner3,
  6. T. Andrew Lister3,
  7. Dominique Bonnet Ph.D.1,*

Article first published online: 1 JUN 2005

DOI: 10.1634/stemcells.2004-0292

Issue

STEM CELLS

STEM CELLS

Volume 23, Issue 6, pages 752–760, June 2005

Additional Information

How to Cite

Pearce, D. J., Taussig, D., Simpson, C., Allen, K., Rohatiner, A. Z., Lister, T. A. and Bonnet, D. (2005), Characterization of Cells with a High Aldehyde Dehydrogenase Activity from Cord Blood and Acute Myeloid Leukemia Samples. STEM CELLS, 23: 752–760. doi: 10.1634/stemcells.2004-0292

Author Information

  1. 1

    Hematopoietic Stem Cell Laboratory, Cancer Research UK, London, United Kingdom

  2. 2

    FACS Laboratory, London Research Institute, Cancer Research UK, London, United Kingdom

  3. 3

    Cancer Research UK Department of Medical Oncology, St. Bartholomew's Hospital, West Smithfield, London, United Kingdom

*Hematopoietic Stem Cell Laboratory, Cancer Research UK, London Research Institute, 44 Lincoln's Inn Fields, London WC2A 3PX, United Kingdom. Telephone: 020-726-93281; Fax: 020-726-93581

Publication History

  1. Issue published online: 2 JAN 2009
  2. Article first published online: 1 JUN 2005
  3. Manuscript Accepted: 1 FEB 2005
  4. Manuscript Received: 21 OCT 2004

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (301K)

References

  • 1
    Yoshida A, Rzhetsky A, Hsu LC et al. Human aldehyde dehydrogenase gene family. Eur J Biochem 1998; 251: 549–557.
    Direct Link:
  • 2
    Sophos NA, Vasiliou V. Aldehyde dehydrogenase gene superfamily: the 2002 update. Chem Biol Interact 2003; 143–144: 5–22.
  • 3
    Wang JS, Fang Q, Sun DJ et al. Genetic modification of hematopoietic progenitor cells for combined resistance to 4-hydroperoxycyclophosphamide, vincristine, and daunorubicin. Acta Pharmacol Sin 2001; 22: 949–955.
  • 4
    Duester G. Families of retinoid dehydrogenases regulating vitamin A function: production of visual pigment and retinoic acid. Eur J Biochem 2000; 267: 4315–4324.
    Direct Link:
  • 5
    Kastan MB, Schlaffer E, Russo JE et al. Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells. Blood 1990; 75: 1947–1950.
  • 6
    Jones RJ, Barber JP, Vala MS et al. Assessment of aldehyde dehydrogenase in viable cells. Blood 1995; 85: 2742–2746.
  • 7
    Storms RW, Trujillo AP, Springer JB et al. Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc Natl Acad Sci U S A 1999; 96: 9118–9123.
  • 8
    Sutherland HJ, Blair A, Zapf RW. Characterization of a hierarchy in human acute myeloid leukemia progenitor cells. Blood 1996; 87: 4754–4761.
  • 9
    Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997; 3: 730–737.
  • 10
    de Groot CJ, Martens AC, Hagenbeek A. Aldehyde dehydrogenase involvement in a variant of the brown Norway rat acute myelocytic leukaemia (BNML) that acquired cyclophosphamide resistance in vivo. Eur J Cancer 1994; 30A: 2137–2143.
  • 11
    Russo JE, Hilton J. Characterization of cytosolic aldehyde dehydrogenase from cyclophosphamide resistant L1210 cells. Cancer Res 1988; 48: 2963–2968.
  • 12
    Takebe N, Zhao SC, Adhikari D et al. Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene. Mol Ther 2001; 3: 88–96.
  • 13
    Moreb JS, Maccow C, Schweder M et al. Expression of antisense RNA to aldehyde dehydrogenase class-1 sensitizes tumor cells to 4-hydroperoxycyclophosphamide in vitro. J Pharmacol Exp Ther 2000; 293: 390–396.
  • 14
    Bhatia M, Bonnet D, Murdoch B et al. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med 1998; 4: 1038–1045.
  • 15
    Hess DA, Meyerrose TE, Wirthlin L et al. Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood 2004; 104: 1648–1655.
  • 16
    Goodell MA, Rosenzweig M, Kim H et al. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med 1997; 3: 1337–1345.
  • 17
    Hess DA, Meyerrose TE, Wirthlin L et al. Functional characterization of highly purified human hematopoietic repopulating cells isolated based on aldehyde dehydrogenase activity. Blood 2004; 104: 1648–1655.
  • 18
    Gallacher L, Murdoch B, Wu DM et al. Isolation and characterization of human CD34−Lin− and CD34+Lin− hematopoietic stem cells using cell surface markers AC133 and CD7. Blood 2000; 95: 2813–2820.
  • 19
    Storms RW, Goodell MA, Fisher A et al. Hoechst dye efflux reveals a novel CD7+CD34− lymphoid progenitor in human umbilical cord blood. Blood 2000; 96: 2125–2133.
  • 20
    Guan Y, Ralph S, Hogge DE. Polyclonal normal hematopoietic progenitors in patients with acute myeloid leukemia. Exp Hematol 2002; 30: 721–728.
  • 21
    Feuring-Buske M, Hogge DE. Hoechst 33342 efflux identifies a sub-population of cytogenetically normal CD34+CD38− progenitor cells from patients with acute myeloid leukemia. Blood 2001; 97: 3882–3889.
  • 22
    Wulf GG, Wang RY, Kuehnle I et al. A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia. Blood 2001; 98: 1166–1173.
  • 23
    Tallman MS, Andersen JW, Schiffer CA et al. All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol. Blood 2002; 100: 4298–4302.
  • 24
    Tallman MS. Differentiating therapy with all-trans retinoic acid in acute myeloid leukemia. Leukemia 1996; 10 (suppl 1):S12–S15.
  • 25
    Russo J, Barnes A, Berger K et al. 4-(N, N-dipropylamino) benzaldehy de inhibits the oxidation of all-trans retinal to all-trans retinoic acid by ALDH1A1, but not the differentiation of HL-60 promyelocytic leukemia cells exposed to all-trans retinal. BMC Pharmacol 2002; 2: 4.
View Full Article (HTML) Get PDF (301K)